| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
6,139,806 | 5,399,424 | 3,926,310 | 2,886,172 | 2,257,294 |
| Cost of Revenue
|
-3,702,865 | -3,252,837 | -2,413,370 | -1,790,819 | -1,420,402 |
|
Gross Profit
|
2,436,941 | 2,146,587 | 1,512,940 | 1,095,353 | 836,892 |
| Selling, General and Administrative Expenses
|
-817,646 | -734,230 | -616,301 | -451,013 | -348,756 |
| Provision Expense/Write-Back
|
-97,539 | -80,830 | -51,942 | -34,027 | -25,678 |
| Other Income/Expense, Operating
|
-27,104 | -26,342 | -6,248 | -6,495 | -59,074 |
|
Operating Income/Expenses
|
-942,289 | -841,402 | -674,491 | -491,535 | -407,830 |
|
Total Operating Profit/Loss
|
1,494,652 | 1,305,185 | 838,449 | 603,818 | 429,062 |
| Total Net Finance Income/Expense
|
-221,797 | -198,285 | -114,377 | -80,049 | -24,437 |
| Net Investment Income
|
180,269 | 157,861 | 91,832 | 67,785 | 379 |
| Irregular Income/Expenses
|
-47,400 | -44,515 | -27,308 | -23,525 | -26,569 |
|
Non-Operating Income/Expenses, Total
|
-88,928 | -84,939 | -49,853 | -35,789 | -24,058 |
|
Pretax Income
|
1,405,724 | 1,220,246 | 788,596 | 568,029 | 405,004 |
| Provision for Income Tax
|
-162,948 | -139,026 | -89,784 | -72,418 | -56,564 |
|
Net Income from Continuing Operations
|
1,242,776 | 1,081,220 | 698,812 | 495,611 | 348,440 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,242,776 | 1,081,220 | 698,812 | 495,611 | 348,440 |
|
Non-Controlling/Minority Interests
|
-144,128 | -105,684 | -48,969 | -13,846 | -18,555 |
|
Net Income after Non-Controlling/Minority Interests
|
1,098,648 | 975,536 | 649,843 | 481,765 | 329,885 |
|
Net Income Available to Common Stockholders
|
1,098,648 | 975,536 | 649,843 | 481,765 | 329,885 |
|
Diluted Net Income Available to Common Stockholders
|
1,098,648 | 975,536 | 649,843 | 481,765 | 329,885 |
| Basic EPS
|
3.65 | 3.33 | 2.24 | 1.66 | 1.13 |
| Diluted EPS
|
3.65 | 3.33 | 2.24 | 1.66 | 1.13 |
|
Basic Weighted Average Shares Outstanding
|
300,977.25 | 292,891 | 289,884.29 | 290,873.92 | 292,878.36 |
|
Diluted Weighted Average Shares Outstanding
|
300,977.25 | 292,891 | 289,884.29 | 290,873.92 | 292,878.36 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,556,173 | 1,373,199 | 865,614 | 613,064 | 429,441 |
|
EBITDA
|
1,590,664 | 1,408,077 | 896,743 | 638,936 | 453,037 |
|
Normalized EBITDA
|
1,638,064 | 1,452,592 | 859,200 | 613,800 | 456,300 |
|
Normalized Income
|
1,284,681.53 | 1,120,829.45 | 724,350.23 | 516,305.94 | 348,440 |
|
Total Unusual Items
|
47,400 | 44,515 | 28,656 | 23,525 | 0 |
12/31/2022 - 9/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade